- 全部删除
- 您的购物车当前为空
Cochliodone A 是一种从深海衍生真菌Chaetomium sp.培养物中分离的活性化合物,展示出了抗细菌和抗癌的特性。该化合物对多种细菌显示出有效的抑制作用,其最小抑菌浓度(MICs)分别为:V. vulnificus 15.3 μg/mL,V. rotiferianus 32.7 μg/mL,S. aureus ATCC 43300 15.9 μg/mL 和 S. aureus CGMCC 1.12409 16.3 μg/mL。Cochliodone A 同时对不同的癌细胞系也有抑制效果,其半数抑制浓度(IC50s)分别为:A549 28.1 μM,HeLa 20.7 μM,和 Hep G2 23.2 μM。
Cochliodone A 是一种从深海衍生真菌Chaetomium sp.培养物中分离的活性化合物,展示出了抗细菌和抗癌的特性。该化合物对多种细菌显示出有效的抑制作用,其最小抑菌浓度(MICs)分别为:V. vulnificus 15.3 μg/mL,V. rotiferianus 32.7 μg/mL,S. aureus ATCC 43300 15.9 μg/mL 和 S. aureus CGMCC 1.12409 16.3 μg/mL。Cochliodone A 同时对不同的癌细胞系也有抑制效果,其半数抑制浓度(IC50s)分别为:A549 28.1 μM,HeLa 20.7 μM,和 Hep G2 23.2 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 8-10周 | |
50 mg | 询价 | 8-10周 |
产品描述 | Cochliodone A, a bioactive compound isolated from the deep-sea fungus Chaetomium sp., exhibits both antibacterial and anticancer properties. This substance demonstrates toxicity against multiple bacterial strains, as evidenced by its minimum inhibitory concentrations (MICs) of 15.3 μg/mL for V. vulnificus, 32.7 μg/mL for V. rotiferianus, 15.9 μg/mL for S. aureus ATCC 43300, and 16.3 μg/mL for S. aureus CGMCC 1.12409. Additionally, Cochliodone A effectively inhibits several cancer cell lines, with half-maximal inhibitory concentrations (IC50s) recorded at 28.1 μM for A549, 20.7 μM for HeLa, and 23.2 μM for Hep G2 [1]. |
分子量 | 638.66 |
分子式 | C34H38O12 |
CAS No. | 1072931-48-6 |
存储 | Shipping with blue ice. |
评论内容